Pleiogenix, leveraging 4 NIH grants, has repurposed a type 2 diabetes drug to develop a safe, non-steroid, first-in-class treatment for Alcoholic Hepatitis
H., Linseman D
For a deeper look at the ingredient itself, you can also explore our Knowledge Center entry on glutathione
Tu MY, Chen HL, Tung YT, Kao CC, Hu FC, Chen CM
34 Both patients saw clinical improvement in psoriasis following liraglutide therapy
Worryingly however, 26.8% of patients had to discontinue the trial due to the severity of side-effects, although it must be noted that this was in part due to the lack of a run-in (A time frame where drug dosage is started from a low dosage and then escalated over time until the highest tolerable dose for the patient is reached) [40]